Skip to content

Clinical trials

Completed Phase 1 Carcinoma, Bronchogenic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Bronchogenic Phase: Phase 1 Status: Completed Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20121
20131
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lee Moffitt Cancer Center and Research Institute1
National Institutes of Health Clinical Center (CC)1
Pharmacyclics LLC.1
Revolution Medicines, Inc.1
Syndax Pharmaceuticals1
Valerio Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Bronchogenic6
Carcinoma, Non-Small-Cell Lung5
Lung Neoplasms5
Neoplasms4
Lung Diseases3
Neoplasms by Site3
Respiratory Tract Diseases3
Respiratory Tract Neoplasms3
Thoracic Neoplasms3
Breast Neoplasms2

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.